Lucid Diagnostics Releases Positive Data from First Prospective Clinical Utility Study of EsoGuard® Esophageal Precancer Detection
Multicenter observational study documents excellent concordance of EsoGuard results with subsequent medical decision-making by multiple physicians NEW YORK, Sept. 7, 2023 /PRNewswire/ -- Lucid...
Lishan Aklog Pavmed Inc Exchange Commission Lucid Diagnostics Inc Lucid Diagnostics Clinical Utility Study
Source: marketscreener.com